Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
Withdrawn

Alternative analysis of mpox vaccine effectiveness data from Israel

View ORCID ProfileChristopher B. Boyer, View ORCID ProfileMarc Lipsitch
doi: https://doi.org/10.1101/2023.02.22.23286243
Christopher B. Boyer
1Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA 02115 USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher B. Boyer
  • For correspondence: cboyer@hsph.harvard.edu
Marc Lipsitch
1Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA 02115 USA
Dphil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc Lipsitch
  • Abstract
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

The authors have withdrawn their manuscript owing to a misunderstanding about the nature of the time-dependent analysis conducted by Wolff Sagy et al. Specifically, in an exchange the authors clarified that they did not reset the time variable in their analysis of person-time among the vaccinated, but split the observation at the time of vaccination and introduced a time-dependent indicator of vaccination. The authors stand by the general point that observational studies of vaccination during an outbreak should be aware of the potential confounding effects of calendar time and immortal time bias. However, the authors do not wish this work to be cited as specific comment on the analysis of Wolff Sagy et al. If you have any questions, please contact the corresponding author.

Competing Interest Statement

ML is, in addition to his academic role, Director for Science, Center for Forecasting and Outbreak Analytics, US Centers for Disease Control and Prevention. This communication is in his academic capacity and does not necessarily represent the views of any government body.

Funding Statement

This study was supported by a gift from the Morris-Singer Fund to the Center for Communicable Disease Dynamics at the Harvard Chan School of Public Health and by a subcontract from US NIH grant R01GM139926

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • The authors have withdrawn their manuscript owing to a missing understanding about the nature of the time-dependent analysis conducted by Wolff Sagy et al. Specifically, in an exchange the authors clarified that they did not reset the time variable in their analysis of person-time among the vaccinated, but split the observation at the time of vaccination and introduced a time-dependent indicator of vaccination. The authors stand by the general point that observational studies of vaccination during an outbreak should be aware of the potential confounding effects of calendar time and immortal time bias. However, the authors do not wish this work to be cited as specific comment on the analysis of Wolff Sagy et al. If you have any questions, please contact the corresponding author.

  • This revision responds to important comments from the authors of the original paper (v1) and from anonymous reviewers of v1. Notably the authors of the original paper (Wolff Sagy et al.) pointed out an important misunderstanding underlying the analysis of v1. The conclusions have significantly changed relative to that first version and we urge readers to note the updated conclusions, notably that the extent of bias inferred in the current version is less than that inferred in v1. Moreover, this version (v2) provides a broader context of the situations (using simulated data) in which bias can arise and the ability of various analytic approaches can make unbiased estimates of vaccine effectiveness.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted June 26, 2023.
Download PDF
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Alternative analysis of mpox vaccine effectiveness data from Israel
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Alternative analysis of mpox vaccine effectiveness data from Israel
Christopher B. Boyer, Marc Lipsitch
medRxiv 2023.02.22.23286243; doi: https://doi.org/10.1101/2023.02.22.23286243
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Alternative analysis of mpox vaccine effectiveness data from Israel
Christopher B. Boyer, Marc Lipsitch
medRxiv 2023.02.22.23286243; doi: https://doi.org/10.1101/2023.02.22.23286243

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)